Breast cancer
Conditions
Interventions
Group 1:Xiaojin pills monotherapy
Group 2:levothyroxine monotherapy
Group 3::Xiaojin pills and levothyroxine combination therapy
Sponsors
Department of Endocrine and Breast Surgery of the First Affiliated Hospital of Chongqing Medical University
Eligibility
Sex/Gender
Female
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Diagnosis as breast cancer according to clinical practice guideline; 2. Performed the operation and all cycles of chemotherapy; 3. Volunteered for this study and informed consent was abtained from the participants; 4. Aged between 18 and 75 years old; 5. Detected thyroid nodule by color Doppler ultrasonography, whether single nodule or multiple nodules, and the nodules <2cm with clear margin and without malignant signs; 6. Normal thyroid function; 7. Informed consent was abtained from the participants.
Exclusion criteria
Exclusion criteria: 1. Those who havent finished systemic treatment of breast cancer; 2. Thyroid dysfunction; 3. Those whos thyroid malignant cant be ruled out by color Doppler ultrasonography; 4. Coexistence of other serious medical conditions, such as serious infections, organs failure, serious injury, etc.; 5. Pregnant women; 6. Allergic to Xiaojin pills; 7. Liver function and renal function dysfunction(the values higher than one time of normal).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate;Excellent rate;Effective rate;Ineffectiveness rate;Total effective rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects; | — |
Countries
China
Contacts
Public ContactRen Guosheng; Kong Lingquan
Department of Endocrine and Breast Surgery of the First Affiliated Hospital of Chongqing Medical University
Outcome results
None listed